Back to my company list

Pepticom

The AI engine Fit Assessment

Beta

Pepticom leverages machine learning to discover innovative peptide therapeutics, optimizing the drug discovery process and expanding therapeutic options.

Blurb

Pepticom is an Artificial Intelligence (AI) company for the discovery of novel molecules in the Pharmaceutical and Agricultural markets.

HQ Location

Israel

Founded

2011

Employees

11 - 50

Total funding raised

$7.60M

Last Funding Event

Venture - Series Unknown, $2.60M, March 9, 2021

Smart insights

  • Catherine Msc (Chief People Officer) worked at Lilium as Head of People Business Partnering for 1.5 years (2021 - 2022)
  • Val Miftakhov (Founder & CEO) worked at Google in various roles, including Head of R&D, Google for Work Incubation, for a total of 4 years (2012 - 2016)
  • 6m headcount growth: 25%
  • 1Y headcount growth: 94%
  • Headcount-to-last-round ratio: 5.3 employees/$M
Subspaces
  • Drug Discovery Optimization

Developer of a biotechnology company intended to streamline the drug discovery process using artificial intelligence. The company's platform offers technology that decreases the cost and time of drug discovery and improves current treatments for today's many unaddressed diseases, addresses the problem of inefficiency around the design and discovery of therapeutics, enabling healthcare professionals with cell permeability, and an infinite chemical space that provides significant advantages over other therapeutic modalities.